{
    "nctId": "NCT00909909",
    "briefTitle": "Radiation Therapy in Treating Women With Early Stage Breast Cancer",
    "officialTitle": "Safety and Feasibility of Accelerated, Hypofractionated Radiotherapy in Women With Breast Cancer: A Phase II Trial",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Loco-regional control as assessed by physical examination, mammography, and other relevant imaging",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Histologically confirmed breast cancer, including 1 of the following subtypes:\n\n  * Ductal carcinoma in situ\n  * Invasive ductal carcinoma\n  * Invasive lobular carcinoma\n  * Medullary carcinoma\n  * Papillary carcinoma\n  * Colloidal (mucinous) carcinoma\n  * Tubular carcinoma\n* Pathological stage 0-IIIA disease (pTis; pT1-2, N0-N2a, M0)\n\n  * Tumor size \u2264 5 cm\n* Breast considered technically satisfactory for radiotherapy\n* Has undergone lumpectomy or mastectomy and either sentinel node biopsy or axillary dissection (if invasive carcinoma is present)\n\n  * Negative inked histological margins (i.e., no invasive cells at surgical margin) or confirmed negative re-excision specimen\n* Unifocal or multifocal (confined to 1 quadrant; tumors \\< 4 cm apart) disease with 1 or 2 foci that can be encompassed by 1 lumpectomy\n* No proven multicentric carcinoma (tumors in different quadrants of the breast or tumor separated by \u2265 4 cm) with other clinically or radiographically suspicious areas in the ipsilateral breast unless confirmed to be negative for malignancy by biopsy\n* No evidence of suspicious microcalcifications in the breast before the start of radiotherapy\n\n  * If malignancy-associated microcalcifications were initially present, the post-excision mammography must be negative\n* No more than 9 positive axillary lymph nodes\n* No palpable or radiographically suspicious contralateral axillary, supraclavicular, infraclavicular, or internal mammary nodes unless there is histologic confirmation that these nodes are negative for tumor\n* No previously treated contralateral breast cancer or synchronous ipsilateral breast cancer\n* No lobular carcinoma in situ alone (i.e., no invasive component) or non-epithelial breast malignancies (e.g., sarcoma or lymphoma)\n* No Paget disease of the nipple\n* No skin involvement, regardless of tumor size\n* No distant metastases\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Pre- or post-menopausal\n* ECOG performance status 0-1\n* No co-existing medical condition that would limit life expectancy to \\< 2 years\n* Not pregnant or nursing\n* Negative pregnancy test\n* Fertile patients must use effective contraception\n* No other malignancy within the past 5 years except for nonmelanoma skin cancer (the disease-free interval from any prior malignancy must be continuous)\n* No collagen vascular disease, specifically systemic lupus erythematosus, scleroderma, or dermatomyositis\n* No psychiatric or addictive disorder that would preclude obtaining informed consent\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics\n* No prior radiotherapy for the current breast cancer\n* No tylectomies so extensive that the cosmetic result is low or poor prior to radiotherapy\n* Chemotherapy allowed provided the following criteria are met:\n\n  * Chemotherapy is not administered prior to, during, and for \u2265 21 days after completion of radiotherapy (for patients receiving brachytherapy boost)\n  * Chemotherapy is not administered for \u2265 21 days before, during, and for \u2265 21 days after completion of radiotherapy (for patients receiving external beam radiotherapy boost or chest wall irradiation)\n* Concurrent tamoxifen, anastrozole, or other hormonal therapy allowed\n\n  * May be initiated before, during, or after radiotherapy\n* No other concurrent chemotherapy, immunotherapy, or experimental medications",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}